Bristol-Myers Squibb Co (BMY) Volatility Spurs A Quest For Clarity
Currently, there are 2.04B common shares owned by the public and among those 2.03B shares have been available to trade. The company’s stock has a 5-day price change of 2.66% and -19.02% over the past three months. BMY shares are trading -14.64% year to date (YTD), with the 12-month market performance up to 19.24% higher. […]
Analyst Expect Big Moves From Bristol-Myers Squibb Co (NYSE: BMY)
Currently, there are 2.04B common shares owned by the public and among those 2.03B shares have been available to trade. The company’s stock has a 5-day price change of -1.99% and -13.25% over the past three months. BMY shares are trading -16.51% year to date (YTD), with the 12-month market performance up to 5.99% higher. […]
Bristol-Myers Squibb Co (NYSE: BMY) Seen Running Too Hot, Let’s Look At This More Closely
Currently, there are 2.04B common shares owned by the public and among those 2.03B shares have been available to trade. The company’s stock has a 5-day price change of -8.15% and -18.29% over the past three months. BMY shares are trading -17.87% year to date (YTD), with the 12-month market performance up to 5.47% higher. […]
Bristol-Myers Squibb Co (NYSE: BMY): The Best-Of-Breed For Investing?
Currently, there are 2.04B common shares owned by the public and among those 2.03B shares have been available to trade. The company’s stock has a 5-day price change of 5.57% and -14.22% over the past three months. BMY shares are trading -10.59% year to date (YTD), with the 12-month market performance up to 15.09% higher. […]
Bristol-Myers Squibb Co (NYSE: BMY) – Suitable For Long Term Buy?
Currently, there are 2.04B common shares owned by the public and among those 2.03B shares have been available to trade. The company’s stock has a 5-day price change of -2.70% and -19.73% over the past three months. BMY shares are trading -15.31% year to date (YTD), with the 12-month market performance down to -2.22% lower. […]
Bristol-Myers Squibb Co. (BMY): Street Finally Waking Up
Currently, there are 2.02B common shares owned by the public and among those 2.02B shares have been available to trade. Insiders at the company have transacted a total of 136 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 85 of these insider trades were purchases, […]
Why Should You Put Bristol-Myers Squibb Co. (NYSE: BMY) On Your Portfolio?
Currently, there are 2.02B common shares owned by the public and among those 2.02B shares have been available to trade. Insiders at the company have transacted a total of 136 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 85 of these insider trades were purchases, […]
Now Is A Suitable Moment For A Long-Term Purchase Of Bristol-Myers Squibb Co. (NYSE: BMY)
Currently, there are 2.10B common shares owned by the public and among those 2.03B shares have been available to trade. Insiders at the company have transacted a total of 136 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 85 of these insider trades were purchases, […]
Bristol-Myers Squibb Co. (BMY) Volatility Spurs A Quest For Clarity
Currently, there are 2.10B common shares owned by the public and among those 2.03B shares have been available to trade. Insiders at the company have transacted a total of 138 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 85 of these insider trades were purchases, […]
Bristol-Myers Squibb Co. (NYSE: BMY): The Best-Of-Breed For Investing?
Insiders at the company have transacted a total of 140 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 86 of these insider trades were purchases, accounting for 710,591 shares. Insider sales of the common stock occurred on 54 occasions, with total insider shares sold totaling […]